EN
WuXi AppTec raises 2026 revenue outlook after nine-month profit surges 62.4%
WuXi AppTec lifts its 2026 revenue forecast after nine-month profit rose 62.4% and revenue increased 38.6% on strong service demand.
biotech
EN
EN
Asian investors double down on surgical robotics and brain-computer interfaces
Private equity funds in Asia double, focusing on surgical robotics and brain-computer interfaces amid growing healthcare innovation.
EN
Chinese biotech firms turn to licensing deals over IPOs for funding
Chinese biotech companies shift to out-licensing agreements to fund drug development as global pharmaceutical firms tighten deal budgets and IPO activity s
EN
Global Pharma Giants Boost Investment in China's Biotech Sector
Global pharma companies are investing in China's biotech sector to drive innovation and unlock valuation growth, as highlighted at the Global Health …
EN
Wuxi AppTec reports 33.7% profit surge despite US scrutiny
Wuxi AppTec sees a 33.7% net profit rise in H1 2026, driven by US sales despite scrutiny. Strong growth highlights resilience in …